table of content
1 Introduction to Research & Analysis Reports
1.1 Biosimilars & Follow-on-biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilars & Follow-on-biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilars & Follow-on-biologics Overall Market Size
2.1 Global Biosimilars & Follow-on-biologics Market Size: 2022 VS 2029
2.2 Global Biosimilars & Follow-on-biologics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biosimilars & Follow-on-biologics Players in Global Market
3.2 Top Global Biosimilars & Follow-on-biologics Companies Ranked by Revenue
3.3 Global Biosimilars & Follow-on-biologics Revenue by Companies
3.4 Top 3 and Top 5 Biosimilars & Follow-on-biologics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biosimilars & Follow-on-biologics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilars & Follow-on-biologics Players in Global Market
3.6.1 List of Global Tier 1 Biosimilars & Follow-on-biologics Companies
3.6.2 List of Global Tier 2 and Tier 3 Biosimilars & Follow-on-biologics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilars & Follow-on-biologics Market Size Markets, 2022 & 2029
4.1.2 Human growth hormone
4.1.3 Erythropoietin
4.1.4 Monoclonal antibodies
4.1.5 Insulin
4.1.6 Interferon
4.1.7 Granulocyte-Colony Stimulating Factor
4.1.8 Others
4.2 By Type - Global Biosimilars & Follow-on-biologics Revenue & Forecasts
4.2.1 By Type - Global Biosimilars & Follow-on-biologics Revenue, 2018-2023
4.2.2 By Type - Global Biosimilars & Follow-on-biologics Revenue, 2024-2029
4.2.3 By Type - Global Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilars & Follow-on-biologics Market Size, 2022 & 2029
5.1.2 Blood Disorders
5.1.3 Oncology Diseases
5.1.4 Chronic and Autoimmune Diseases
5.1.5 Growth Hormone Deficiencies
5.1.6 Others
5.2 By Application - Global Biosimilars & Follow-on-biologics Revenue & Forecasts
5.2.1 By Application - Global Biosimilars & Follow-on-biologics Revenue, 2018-2023
5.2.2 By Application - Global Biosimilars & Follow-on-biologics Revenue, 2024-2029
5.2.3 By Application - Global Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Biosimilars & Follow-on-biologics Market Size, 2022 & 2029
6.2 By Region - Global Biosimilars & Follow-on-biologics Revenue & Forecasts
6.2.1 By Region - Global Biosimilars & Follow-on-biologics Revenue, 2018-2023
6.2.2 By Region - Global Biosimilars & Follow-on-biologics Revenue, 2024-2029
6.2.3 By Region - Global Biosimilars & Follow-on-biologics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Biosimilars & Follow-on-biologics Revenue, 2018-2029
6.3.2 US Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.3.3 Canada Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.3.4 Mexico Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Biosimilars & Follow-on-biologics Revenue, 2018-2029
6.4.2 Germany Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4.3 France Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4.4 U.K. Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4.5 Italy Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4.6 Russia Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4.7 Nordic Countries Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.4.8 Benelux Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Biosimilars & Follow-on-biologics Revenue, 2018-2029
6.5.2 China Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.5.3 Japan Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.5.4 South Korea Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.5.5 Southeast Asia Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.5.6 India Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Biosimilars & Follow-on-biologics Revenue, 2018-2029
6.6.2 Brazil Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.6.3 Argentina Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biosimilars & Follow-on-biologics Revenue, 2018-2029
6.7.2 Turkey Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.7.3 Israel Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.7.4 Saudi Arabia Biosimilars & Follow-on-biologics Market Size, 2018-2029
6.7.5 UAE Biosimilars & Follow-on-biologics Market Size, 2018-2029
7 Biosimilars & Follow-on-biologics Companies Profiles
7.1 Novartis (Sandoz)
7.1.1 Novartis (Sandoz) Company Summary
7.1.2 Novartis (Sandoz) Business Overview
7.1.3 Novartis (Sandoz) Biosimilars & Follow-on-biologics Major Product Offerings
7.1.4 Novartis (Sandoz) Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.1.5 Novartis (Sandoz) Key News & Latest Developments
7.2 Synthon Pharmaceuticals
7.2.1 Synthon Pharmaceuticals Company Summary
7.2.2 Synthon Pharmaceuticals Business Overview
7.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-biologics Major Product Offerings
7.2.4 Synthon Pharmaceuticals Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.2.5 Synthon Pharmaceuticals Key News & Latest Developments
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Company Summary
7.3.2 Teva Pharmaceutical Industries Business Overview
7.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-biologics Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.3.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.4 LG Life Sciences
7.4.1 LG Life Sciences Company Summary
7.4.2 LG Life Sciences Business Overview
7.4.3 LG Life Sciences Biosimilars & Follow-on-biologics Major Product Offerings
7.4.4 LG Life Sciences Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.4.5 LG Life Sciences Key News & Latest Developments
7.5 Celltrion Biocon
7.5.1 Celltrion Biocon Company Summary
7.5.2 Celltrion Biocon Business Overview
7.5.3 Celltrion Biocon Biosimilars & Follow-on-biologics Major Product Offerings
7.5.4 Celltrion Biocon Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.5.5 Celltrion Biocon Key News & Latest Developments
7.6 Hospira
7.6.1 Hospira Company Summary
7.6.2 Hospira Business Overview
7.6.3 Hospira Biosimilars & Follow-on-biologics Major Product Offerings
7.6.4 Hospira Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.6.5 Hospira Key News & Latest Developments
7.7 Merck Serono (Merck)
7.7.1 Merck Serono (Merck) Company Summary
7.7.2 Merck Serono (Merck) Business Overview
7.7.3 Merck Serono (Merck) Biosimilars & Follow-on-biologics Major Product Offerings
7.7.4 Merck Serono (Merck) Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.7.5 Merck Serono (Merck) Key News & Latest Developments
7.8 Biogen idec
7.8.1 Biogen idec Company Summary
7.8.2 Biogen idec Business Overview
7.8.3 Biogen idec Biosimilars & Follow-on-biologics Major Product Offerings
7.8.4 Biogen idec Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.8.5 Biogen idec Key News & Latest Developments
7.9 Genentech (Roche)
7.9.1 Genentech (Roche) Company Summary
7.9.2 Genentech (Roche) Business Overview
7.9.3 Genentech (Roche) Biosimilars & Follow-on-biologics Major Product Offerings
7.9.4 Genentech (Roche) Biosimilars & Follow-on-biologics Revenue in Global Market (2018-2023)
7.9.5 Genentech (Roche) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
